Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Geller

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Depression and Anxiety|January 27, 2022
Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trialLara J Farrell, Allison M Waters, Evelin Tiralongo, et al.
Journal of Child and Adolescent Psychopharmacology|June 7, 2019
Immune-Related Comorbidities in Childhood-Onset Obsessive Compulsive Disorder: Lifetime Prevalence in the Obsessive Compulsive Disorder Collaborative Genetics Association StudyClara Westwell-Roper, Kyle A Williams, Jack Samuels, et al.
European Child & Adolescent Psychiatry|April 18, 2024
Exploring latent clusters in pediatric OCD based on symptoms, severity, age, gender, and comorbidityOrri Smárason, Robert R Selles, Davíð R M A Højgaard, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 30, 2011
Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorderJack Samuels, Ying Wang, Mark A Riddle, et al.
CNS Spectrums|November 3, 2025
Moving beyond symptom subtypes: testing a common dimension of lifetime OCD symptomsAbel S Mathew, Sarah L Garnaat, David R Strong, et al.
Journal of Child and Adolescent Psychopharmacology|November 11, 2022
Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory TherapiesJennifer Frankovich, Susan Swedo, Tanya Murphy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 19, 2019
Early intervention for obsessive compulsive disorder: An expert consensus statementNaomi A Fineberg, Bernardo Dell'Osso, Umberto Albert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2021
Is Persistent Motor or Vocal Tic Disorder a Milder Form of Tourette Syndrome?Karla Claudio-Campos, Daniel Stevens, Sang-Wahn Koo, et al.
JAMA Psychiatry|January 26, 2017
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant DataDavid Mataix-Cols, Lorena Fernández de la Cruz, Benedetta Monzani, et al.
Journal of Anxiety Disorders|November 8, 2019
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysisDavid Rosenfield, Jasper A J Smits, Stefan G Hofmann, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Depression and Anxiety|January 27, 2022
Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trialLara J Farrell, Allison M Waters, Evelin Tiralongo, et al.
Journal of Child and Adolescent Psychopharmacology|June 7, 2019
Immune-Related Comorbidities in Childhood-Onset Obsessive Compulsive Disorder: Lifetime Prevalence in the Obsessive Compulsive Disorder Collaborative Genetics Association StudyClara Westwell-Roper, Kyle A Williams, Jack Samuels, et al.
European Child & Adolescent Psychiatry|April 18, 2024
Exploring latent clusters in pediatric OCD based on symptoms, severity, age, gender, and comorbidityOrri Smárason, Robert R Selles, Davíð R M A Højgaard, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 30, 2011
Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorderJack Samuels, Ying Wang, Mark A Riddle, et al.
CNS Spectrums|November 3, 2025
Moving beyond symptom subtypes: testing a common dimension of lifetime OCD symptomsAbel S Mathew, Sarah L Garnaat, David R Strong, et al.
Journal of Child and Adolescent Psychopharmacology|November 11, 2022
Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory TherapiesJennifer Frankovich, Susan Swedo, Tanya Murphy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 19, 2019
Early intervention for obsessive compulsive disorder: An expert consensus statementNaomi A Fineberg, Bernardo Dell'Osso, Umberto Albert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2021
Is Persistent Motor or Vocal Tic Disorder a Milder Form of Tourette Syndrome?Karla Claudio-Campos, Daniel Stevens, Sang-Wahn Koo, et al.
JAMA Psychiatry|January 26, 2017
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant DataDavid Mataix-Cols, Lorena Fernández de la Cruz, Benedetta Monzani, et al.
Journal of Anxiety Disorders|November 8, 2019
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysisDavid Rosenfield, Jasper A J Smits, Stefan G Hofmann, et al.
Pageof 7